Unlock instant, AI-driven research and patent intelligence for your innovation.

Scutellarin prodrug using poly-aspartate derivant as the carrier and method for preparing the same

A technology of polyaspartic acid and scutellarin, which can be used in pharmaceutical formulations, medical preparations with non-active ingredients, and medical preparations containing active ingredients, etc. Availability, simple effect of preparation method

Inactive Publication Date: 2009-09-23
NANJING UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the use of polyethylene glycol as a prodrug carrier also has obvious disadvantages, that is, it has certain biological toxicity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Scutellarin prodrug using poly-aspartate derivant as the carrier and method for preparing the same
  • Scutellarin prodrug using poly-aspartate derivant as the carrier and method for preparing the same
  • Scutellarin prodrug using poly-aspartate derivant as the carrier and method for preparing the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Weigh 200 grams of aspartic acid, add 10 grams of concentrated phosphoric acid as a catalyst, carry out polycondensation reaction at 180 ° C, and gradually reduce the pressure to 1 × 10 4 Pa, after 10 hours of reaction, succinimide PSI can be prepared with a yield of 95%.

[0035] Dissolve 5.0 g of PSI in 25 ml of DMF, cool to 0°C, add 13.0 g of diethanolamine dropwise at this temperature, and react at room temperature for 2 h. The mixture was added dropwise to 150ml of n-butanol with constant stirring, and after standing for 1 h, it was filtered and washed with a large amount of acetone until the pH value of the filtrate was neutral. Vacuum drying at room temperature for 24 hours yielded 8.7 g of poly(α,β-N-dihydroxyethyl-DL-asparagine) PDHEA white powder with a yield of 85% and a molecular weight of 2000.

[0036] Dissolve 0.70 g of scutellarin in 20 ml of DMF, and then add the solution dropwise to a solution of 0.30 g of PDHEA in 10 ml of DMF. The above mixture was...

Embodiment 2

[0038] Same as the preparation method of PDHEA in Example 1, the difference is that the reaction time of PSI and diethanolamine is 2.5 hours to obtain PDHEA with a molecular weight of 5000.

[0039]Dissolve 0.47 g of scutellarin in 15 ml of DMF, and then add the solution dropwise to a solution of 0.21 g of PDHEA in 8 ml of DMF. The above mixed solution was stirred well, 0.47 g of DMAP was added, and the reaction was stirred. Dissolve 0.8 g of DCC in an appropriate amount of 20 ml of DMF to form a colorless solution, which is added dropwise to the above mixture. The reaction was stirred at 50°C. After 72 hours, filter with slow filter paper, take the clear part and place it in a pear-shaped bottle, and evaporate to dryness. Wash the light green solid on the wall of the pear-shaped bottle with n-propanol, filter, wash the solid with n-propanol until the filtrate is colorless, and dry the precipitate under vacuum at 40°C to obtain 0.35 g of light green solid scutellarin prodrug...

Embodiment 3

[0041] Same as the preparation method of PDHEA in Example 1, the difference is that the reaction time of PSI and diethanolamine is 4 hours to obtain PDHEA with a molecular weight of 20,000.

[0042] 1.41 g of scutellarin was dissolved in 60 ml of DMF, and then the solution was added dropwise to a solution of 0.92 g of PDHEA in 30 ml of DMF. The above mixed solution was stirred well, 2.8 g of DMAP was added, and the reaction was stirred. 0.50 g of DCC was dissolved in 25 ml of DMF to form a colorless solution, which was added dropwise to the above mixture. After stirring and reacting at 20°C for 12 hours, filter with slow filter paper, take the clear liquid, place it in a pear-shaped bottle, and evaporate to dryness. Wash the light green solid on the wall of the pear-shaped bottle with n-propanol, filter, wash the solid with n-propanol until the filtrate is colorless, and vacuum-dry the precipitate at 60°C to obtain 1.39 g of light green solid scutellarin prodrug PDHEAS, The ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
solubility (mass)aaaaaaaaaa
solubility (mass)aaaaaaaaaa
degree of graftingaaaaaaaaaa
Login to View More

Abstract

The invention provides a kind of scutellarin pro-drug taking poly-aspartate derivative as vector, and the preparation method, which takes poly-aspartate derivant poly-(alpha, beta-N, N-dihydroxyethyl-DL-aspartamide, PDHEA)as vector, taking N, N-dicyclo hexylcar bodiimide (DCC)as condensing agent, and produces new-type scutellarin pro-drug through esterification reaction between poly-aspartate derivative and scutellarin. There are more active carboxy groups on main chain of scutellarin pro-drug, which is favorable for increasing pro-drug water solubility and biological utilization rate of scutellarin. The preparation method is simple and is easy to carry out.

Description

technical field [0001] The invention relates to a macromolecular prodrug and a preparation method thereof, in particular to a scutellarin prodrug and a preparation method thereof. technical background [0002] Scutellarin, also known as scutellarin, is the main component of scutellarin extracted from the plant Erigeron breviscapus of Compositae, and belongs to flavonoids. It has been proven to dilate blood vessels, increase cardiac coronary flow, increase cerebral blood flow, reduce cerebrovascular resistance, improve blood-brain barrier permeability, and resist platelet aggregation caused by adenosine diphosphate. It has been used clinically for many years. Clinically, it is mainly used to treat cerebral thrombosis, cerebral infarction, paralysis after stroke, coronary heart disease, angina pectoris and other diseases, with definite curative effect. Its existing preparations include common tablets, injections and injection powders. Oral bioavailability of ordinary tablets...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/48A61K47/34A61K31/7048A61P7/02A61P9/10A61K47/64
Inventor 沈健陈强迟波林思聪
Owner NANJING UNIV